Novartis AG

NVS

Market cap$294.66 B

Rank#46

Filings981

Novartis AG has filed 981 public company documents between 2009 and 2026. The most frequent type is 6-k (561 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchNVS overview$294.66 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #46See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut NVS beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow NVS via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
6-K	6-K	16y ago2009-12-29	2009-12-21	View filing
6-K	6-K	16y ago2009-12-29	2009-12-23	View filing
6-K	6-K	16y ago2009-12-18	2009-12-18	View filing
6-K	6-K	16y ago2009-12-10	2009-12-09	View filing
6-K	6-K	16y ago2009-12-10	2009-12-08	View filing
6-K	6-K	16y ago2009-12-04	2009-12-02	View filing
6-K	6-K	16y ago2009-12-04	2009-12-03	View filing
6-K	6-K	16y ago2009-11-27	2009-11-25	View filing
6-K	6-K	16y ago2009-11-24	2009-11-24	View filing
6-K	6-K	16y ago2009-11-17	2009-11-17	View filing
6-K	6-K	16y ago2009-11-12	2009-11-12	View filing
6-K	6-K	16y ago2009-11-10	2009-11-04	View filing
6-K	6-K	16y ago2009-11-10	2009-11-05	View filing
6-K	6-K	16y ago2009-11-03	2009-11-03	View filing
6-K	6-K	16y ago2009-10-30	2009-10-28	View filing
6-K	6-K	16y ago2009-10-30	2009-10-29	View filing
F-6EF	F-6EF	16y ago2009-10-29	-	View filing
S-8	Employee stock plan	16y ago2009-10-29	-	View filing
6-K	6-K	16y ago2009-10-27	2009-10-22	View filing
6-K	6-K	16y ago2009-10-27	2009-10-23	View filing
6-K	6-K	16y ago2009-10-21	2009-10-20	View filing
6-K	6-K	16y ago2009-10-20	2009-10-20	View filing
6-K	6-K	16y ago2009-10-19	2009-10-19	View filing
6-K	6-K	16y ago2009-10-15	2009-10-12	View filing
6-K	6-K	16y ago2009-10-08	2009-10-08	View filing
6-K	6-K	16y ago2009-10-06	2009-10-06	View filing
6-K	6-K	16y ago2009-10-01	2009-09-30	View filing
6-K	6-K	16y ago2009-09-29	2009-09-25	View filing
6-K	6-K	16y ago2009-09-29	2009-09-25	View filing
6-K	6-K	16y ago2009-09-29	2009-09-24	View filing
6-K	6-K	16y ago2009-09-21	2009-09-17	View filing
6-K	6-K	16y ago2009-09-16	2009-09-15	View filing
UPLOAD	SEC correspondence	16y ago2009-09-16	-	View filing
6-K	6-K	16y ago2009-09-04	2009-09-03	View filing
4/A	Insider trade (amended)	16y ago2009-09-01	2009-08-21	View filing
4	Insider trade	16y ago2009-08-24	2009-08-21	View filing
6-K	6-K	16y ago2009-08-24	2009-08-24	View filing
6-K	6-K	16y ago2009-08-21	2009-08-19	View filing
6-K	6-K	16y ago2009-08-17	2009-08-17	View filing
6-K	6-K	16y ago2009-08-13	2009-08-11	View filing
6-K	6-K	16y ago2009-08-07	2009-08-05	View filing
6-K	6-K	16y ago2009-08-07	2009-08-06	View filing
6-K	6-K	16y ago2009-07-27	2009-07-24	View filing
6-K	6-K	16y ago2009-07-23	2009-07-21	View filing
6-K	6-K	16y ago2009-07-17	2009-07-16	View filing
6-K	6-K	17y ago2009-07-09	2009-07-08	View filing
6-K	6-K	17y ago2009-07-06	2009-07-06	View filing
6-K	6-K	17y ago2009-07-02	2009-06-30	View filing
6-K	6-K	17y ago2009-06-30	2009-06-24	View filing
6-K	6-K	17y ago2009-06-30	2009-06-25	View filing

Novartis AG

Similar companies to research next

Year